THNR Holdings
22 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 22 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 10.52% | 503 | $597.9K |
| 2 | Novo Nordisk A/S | 8.64% | 12,835 | $491.1K |
| 3 | CSPC Pharmaceutical Group Ltd (1093.HK) | 5.76% | 262,000 | $327.7K |
| 4 | Amgen Inc | 5.73% | 788 | $325.5K |
| 5 | AbbVie Inc | 5.49% | 1,149 | $311.8K |
| 6 | Roche Holding AG (ROP.SW) | 5.39% | 708 | $306.1K |
| 7 | Pfizer Inc | 5.37% | 10,896 | $305.1K |
| 8 | Innovent Biologics Inc (1801.HK) | 5.36% | 24,500 | $304.4K |
| 9 | AstraZeneca PLC | 5.32% | 1,888 | $302.3K |
| 10 | Gilead Sciences Inc | 5.23% | 2,024 | $297.2K |
| 11 | Merck & Co Inc | 5.09% | 2,025 | $289.1K |
| 12 | Regeneron Pharmaceuticals Inc | 4.96% | 380 | $282.0K |
| 13 | Chugai Pharmaceutical Co Ltd (4519.T) | 4.75% | 7,000 | $270.1K |
| 14 | Viking Therapeutics Inc | 4.58% | 9,118 | $260.2K |
| 15 | Hanmi Pharm Co Ltd (128940.KS) | 3.87% | 552 | $219.9K |
| 16 | Arrowhead Pharmaceuticals Inc | 3.83% | 3,541 | $217.7K |
| 17 | Zealand Pharma A/S (ZEAL.CO) | 3.64% | 5,542 | $207.0K |
| 18 | Structure Therapeutics Inc | 2.86% | 6,098 | $162.7K |
| 19 | Jiangsu Hengrui Pharmaceuticals Co Ltd (1276.HK) | 2.36% | 21,400 | $134.0K |
| 20 | Kailera Therapeutics Inc | 0.92% | 4,979 | $52.4K |
| 21 | Invesco Government & Agency Portfolio 12/31/2031 (AGPXX) | 0.26% | 14,553 | $14.6K |
| 22 | Cash & Other | 0.08% | 4,807 | $4.8K |
Sector Weights
- Cash & Others: -0.73%
- Financial Services: 1.08%
- Healthcare: 99.65%
Country Weights
- United States: 52.04%
- China: 13.72%
- Denmark: 12.20%
- United Kingdom: 5.24%
- Switzerland: 4.66%
- Japan: 4.55%
- Other: 4.02%
- South Korea: 3.56%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.